- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech High Growth Potential Companies
South Korean Pharmaceuticals & Biotech High Growth Potential Companies
Results
21
Companies with a Future performance score of at least 3, ordered by Future performance score.
21 companies
PharmaResearch
Market Cap: ₩5.7t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩550,000.00
7D
0.5%
1Y
185.6%
AprilBioLtd
Market Cap: ₩691.7b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩30,650.00
7D
14.6%
1Y
42.9%
Oscotec
Market Cap: ₩1.7t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩45,400.00
7D
2.3%
1Y
33.7%
ALTEOGEN
Market Cap: ₩25.2t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩471,500.00
7D
3.6%
1Y
40.3%
Macrogen
Market Cap: ₩167.9b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩15,490.00
7D
-0.8%
1Y
-10.7%
SK Biopharmaceuticals
Market Cap: ₩8.1t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩104,000.00
7D
-1.1%
1Y
0.9%
3billion
Market Cap: ₩237.6b
Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.
A394800
₩7,490.00
7D
-6.1%
1Y
n/a
LigaChem Biosciences
Market Cap: ₩5.5t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩152,300.00
7D
3.8%
1Y
55.7%
Hanall Biopharma
Market Cap: ₩1.8t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩34,500.00
7D
10.0%
1Y
-7.8%
Seegene
Market Cap: ₩1.2t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩25,200.00
7D
-0.6%
1Y
5.2%
Medy-Tox
Market Cap: ₩847.2b
Operates as a biopharmaceutical company in South Korea.
A086900
₩120,700.00
7D
-2.1%
1Y
-34.9%
ABL Bio
Market Cap: ₩5.3t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩95,400.00
7D
2.3%
1Y
204.8%
ST PharmLtd
Market Cap: ₩1.8t
Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
A237690
₩88,800.00
7D
-2.4%
1Y
-11.6%
Celltrion
Market Cap: ₩38.6t
A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.
A068270
₩175,400.00
7D
-1.4%
1Y
0.3%
Yuhan
Market Cap: ₩9.0t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩119,900.00
7D
1.6%
1Y
-13.9%
Hanmi Pharm
Market Cap: ₩4.5t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩354,500.00
7D
-5.5%
1Y
12.2%
Hugel
Market Cap: ₩3.1t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩285,500.00
7D
-3.4%
1Y
18.2%
Kolon TissueGene
Market Cap: ₩3.9t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩46,800.00
7D
-4.3%
1Y
235.2%
Dong-A ST
Market Cap: ₩418.1b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩45,650.00
7D
-3.8%
1Y
-33.6%
Humedix
Market Cap: ₩528.4b
Engages in the manufacture and sale of various pharmaceutical products in South Korea.
A200670
₩51,200.00
7D
-11.0%
1Y
59.0%
Daewoong Pharmaceutical
Market Cap: ₩1.5t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩132,300.00
7D
-3.5%
1Y
-2.4%